Answers are grounded in this paper and cite their sources.
Analysis reveals that HIV coinfection increases low-fitness rpoB mutations in drug-resistant TB strains, suggesting a link to weakened immunity.
We analyzed 312 drug-resistant genomes of Mycobacterium tuberculosis isolates collected from HIV-coinfected and HIV-negative TB patients from nine countries with a high tuberculosis burden. We found that rifampicin-resistant M. tuberculosis strains isolated from HIV-coinfected patients carried disproportionally more resistance-conferring mutations in rpoB that are associated with a low fitness in the absence of the drug, suggesting these low-fitness rpoB variants can thrive in the context of reduced host immunity.
No takes yet. Share an insight, caveat, or question.
Loiseau et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: